STOCK TITAN
  1. Home
  2. Sec-filings
  3. RPTX
  4. [8-K] Repare Therapeutics Inc. Reports Material Event

[8-K] Repare Therapeutics Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock RPTX logo
Repare Therapeutics Inc.

NASDAQ:RPTX

RPTX Rankings

#7688 Ranked by Market Cap
N/A Ranked by Dividends

RPTX Latest News

Jul 15, 2025
Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib
May 13, 2025
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
May 1, 2025
Newly Launched DCx Biotherapeutics In-Licenses Discovery Platforms and Retains Talent and Infrastructure From Repare Therapeutics to Accelerate Development of Multi-Modal Antibody Drug Conjugates
May 1, 2025
Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
Apr 25, 2025
Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025

RPTX Latest SEC Filings

Jun 20, 2025
[8-K] Repare Therapeutics Inc. Reports Material Event

RPTX Stock Data

66.91M
39.05M
0.98%
80.17%
2.49%
Biotechnology
Pharmaceutical Preparations
Link
Canada
SAINT-LAURENT